Invest Well in Pfizer Stock: Products, Dividend, Financial Statements, and More
2024-04-07 updated
When making long-term investments to ensure stability through diversified investments, it is recommended to prioritize ETFs that include Pfizer stocks. However, there might still be individuals who wish to invest directly in Pfizer stocks. Shall we also explore a value investing approach to assess whether Pfizer's performance will grow in the long term?
Q. What products and services does Pfizer provide?
Drugs
Vaccines
Animal medicines
- Pfizer is a pharmaceutical company based in the United States.
- It develops drugs for various diseases such as cancer, cardiovascular disease, infectious diseases, and rare diseases.
- It develops vaccines for various diseases such as COVID-19, influenza, and hepatitis B.
- It develops medicines for animals such as pets and livestock.
Q. Is Pfizer's executive CEO honest and competent?
Albert Bourla is the CEO of Pfizer. He leads Pfizer with the goal of driving scientific and commercial innovation needed to bring about change in human health.
- He became CEO in 2019 and is accelerating Pfizer’s transformation with the goal of making Pfizer a company where people and science thrive.
- With experience leading teams across five continents, he understands the needs of patients and healthcare systems around the world and is dedicated to ensuring equitable access to medicines and vaccines.
- He has worked at Pfizer for over 30 years.
- He holds a Doctor of Veterinary Medicine degree.
Q. Is Pfizer's financial statements healthy?
(2024년 04월 06일 기준)
Net Profit Margin
- Pfizer has earned an annual net profit equivalent to 1.41% of the current stock price.
- Thenet profit has been decreasingat an annual rate of -28.25% over the past 5 years, so it's something to be cautious about.
Total Debt
- The debt is 2792.78% of the annual net profit.
- It would take about 28 years for the company to repay all of its debt.
- The net profit is decreasing, so Pfizer should be careful about managing the debt.
Dividend
- Pfizer offers a 6.30% annual dividend.
- Over the past 5 years, the annual average dividend has grown by 3.14%.
- Dividends are growing, which is good.
Q. What is Pfizer's stock performance like?
- This year's total return is -28.78%.
- 5-year mean total return is -4.28%.
Q. When is a good time to buy and sell Pfizer?
If Pfizer is healthy and growing, it will rise in the long run, so it is good to buy in installments even if you think the current stock price is a bit high. On the other hand, if you think that Pfizer is no longer healthy in the long run, you can consider selling.
PER
- Current: 74.06
- 5Y Avg: 24.32
- The current value is higher than the average, so be careful when buying. However, purchasing can be considered only if you judge that the company will sustain high long-term growth.
Price/Sale Ratio
- Current: 2.57
- 5Y Avg: 3.50
- Current value is lower than average so it may be time to consider buying. However, this strategy is only recommended if you are convinced that the company will continue to be healthy and grow in the long term.
#Long-term value investing in Pfizer#Intrinsic value of Pfizer#Introduction and analysis of stock#forecast#products#competitiveness#management CEO#financial statements#net income#debt#ROIC#dividend#treasury stock#return#PER#Price/Sale Ratio#philosophy#fundamental analysis
Value Investing Together is a blog and application that provides stock information for individuals interested in value investing and is not intended for investment recommendations. The information provided should only be used for reference purposes, and investment decisions should be made at one's own discretion and responsibility.